Anna Trask - Dec 2, 2021 Form 4 Insider Report for Decibel Therapeutics, Inc. (DBTX)

Role
CHIEF PEOPLE, COMMUNITY & CULTURE OFFICER
Signature
/s/ Anna Trask
Stock symbol
DBTX
Transactions as of
Dec 2, 2021
Transactions value $
-$33,688
Form type
4
Date filed
12/6/2021, 03:20 PM
Previous filing
Nov 4, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBTX Common Stock Sale -$31.3K -4.91K -65.22% $6.37 2.62K Dec 2, 2021 Direct F1, F2
transaction DBTX Common Stock Sale -$2.39K -378 -14.43% $6.34 2.24K Dec 2, 2021 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.615, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnotes (2) and (3) of this Form 4.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.18 to $6.47, inclusive.

Remarks:

CHIEF PEOPLE, COMMUNITY & CULTURE OFFICER